论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
妊娠期糖尿病及子痫前期生物标志物研究进展
Authors Liu Y, Li DY, Bolatai A, Wu N
Received 24 August 2023
Accepted for publication 31 October 2023
Published 22 November 2023 Volume 2023:16 Pages 3807—3815
DOI https://doi.org/10.2147/DMSO.S433179
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Juei-Tang Cheng
Abstract: Gestational diabetes mellitus (GDM) and preeclampsia (PE) are common complications in pregnancy, with incidence rates of 1– 5% and 9.4%, respectively, in China. Both these phenomena can cause adverse pregnancy outcomes and are extremely harmful to the mother and fetus. In this study, we observed that several predictive factors have important value in GDM and PE. Among the GDM group, abnormal levels of adiponectin (APN), C-reactive protein (CRP), and Leptin were observed. The coexistence of PE and GDM in the pregnant population is not uncommon. Ultimately, we discovered abnormal levels of factors such as Visfatin, Advanced oxidative protein product (AOPP), Fibroblast growth factor 21 (FGF21), and resistin in both GDM and PE groups. Particularly, the FGF21 factor holds significant importance in our research. Therefore, we need to complete the analysis and discussion of relevant predictive factors to enable early prediction and disease monitoring of GDM, PE, and other pregnancy-related disorders, ultimately contributing to the long-term health of pregnant women.
Keywords: gestational diabetes mellitus, preeclampsia, predictor of the GDM and PE